4.6 Review

Extracellular stability of nanoparticulate drug carriers

期刊

ARCHIVES OF PHARMACAL RESEARCH
卷 37, 期 1, 页码 16-23

出版社

PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-013-0286-0

关键词

Nanomedicine; Nanoparticles; Drug delivery; Stability; Sensitivity

资金

  1. NSF [DMR-1056997]
  2. Lilly Endowment, Inc.
  3. Intramural Research Program (Global RNAi Carrier Initiative) of Korea Institute of Science and Technology
  4. NIH/NCRR-Indiana Clinical and Translational Sciences Institute [TL1 RR025759]
  5. Division Of Materials Research
  6. Direct For Mathematical & Physical Scien [1056997] Funding Source: National Science Foundation

向作者/读者索取更多资源

Nanoparticulate (NP) drug carrier systems are attractive vehicles for selective drug delivery to solid tumors. Ideally, NPs should evade clearance by the reticuloendothelial system while maintaining the ability to interact with tumor cells and facilitate cellular uptake. Great effort has been made to fulfill these design criteria, yielding various types of functionalized NPs. Another important consideration in NP design is the physical and functional stability during circulation, which, if ignored, can significantly undermine the promise of intelligently designed NP drug carriers. This commentary reviews several NP examples with stability issues and their consequences, ending in a discussion of experimental methods for reliable prediction of NP stability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据